A Phase III Multinational Multicenter Investigator-Masked Randomised Active-Controlled Trial Comparing the Efficacy and Safety of DE-130A With Xalatan ® in Patients With Open-Angle Glaucoma or Ocular Hypertension
Conditions: Open-Angle Glaucoma or Ocular Hypertension; Ocular Surface Disease Interventions: Drug: DE-130A; Drug: Xalatan® Sponsor: Santen SAS Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials